BioCSL Limited's 2009 clinical trial to assess the immunogenicity and safety of trivalent influenza vaccine in US children raises concern

Paul V. Effler^*, Heath A. Kelly

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Access to Document

@article{2c676b0fd040419892f9d40e5139915c,

title = "BioCSL Limited's 2009 clinical trial to assess the immunogenicity and safety of trivalent influenza vaccine in US children raises concern",

author = "Effler, {Paul V.} and Kelly, {Heath A.}",

year = "2015",

month = oct,

day = "13",

doi = "10.1016/j.vaccine.2015.05.020",

language = "English",

volume = "33",

pages = "5492",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier B.V.",

number = "42",

}

TY - JOUR

T1 - BioCSL Limited's 2009 clinical trial to assess the immunogenicity and safety of trivalent influenza vaccine in US children raises concern

AU - Effler, Paul V.

AU - Kelly, Heath A.

PY - 2015/10/13

Y1 - 2015/10/13

UR - http://www.scopus.com/inward/record.url?scp=84943455424&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2015.05.020

DO - 10.1016/j.vaccine.2015.05.020

M3 - Letter

SN - 0264-410X

VL - 33

SP - 5492

JO - Vaccine

JF - Vaccine

IS - 42

ER -